Traditional approaches to growth in biopharma are no longer sustainable
pharmaphorum
AUGUST 5, 2022
Through our recent report, Scientific innovations for more sustainable growth , we analysed over 300 M&A deals made by the world’s top 30 biopharma companies between 2010–2021. Collaboration across the industry is needed now more than ever before across this complex ecosystem – not least because it’s becoming a competitive landscape.
Let's personalize your content